Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. [electronic resource]
Producer: 20081103Description: 498-505 p. digitalISSN:- 1063-4584
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Chondroitin Sulfates -- pharmacology
- Disease Progression
- Female
- Humans
- Injections, Intra-Articular
- Interleukin 1 Receptor Antagonist Protein -- chemical synthesis
- Male
- Middle Aged
- Osteoarthritis, Knee -- drug therapy
- Placebos
- Prospective Studies
- Severity of Illness Index
- Surveys and Questionnaires
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.